Difference in Preventive Effects Between the Phosphodiesterase IV Inhibitor Rolipram and Anti-Arthritic Drugs on Antigen-Induced Arthritis in Mice

REFERENCES

• Corry D. B., Folkesson H. G., Warnock M. L., Erle D. J., Matthay M. A., Wiener-Kronish J. P., Locksley R. M. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hypersensitivity. J. Exp. Med 1996; 183(1)109–117
   PubMed Web of Science ®Google Scholar
• Dickensheets H. L., Venkataraman C., Schindler U., Donnelly R. P. Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression. Proc. Natl. Acad. Sci. USA 1999; 96(19)10800–10805
   PubMedGoogle Scholar
• Elliot M. J., Maini R. N., Feldmann M., Long-Fox A., Charles P., Bijl H., Woody J. N. Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis. Lancet 1994; 344(8930)1125–1127
   PubMed Web of Science ®Google Scholar
• Feldmann M., Brennan F. M., Maini R. N. Rheumatoid arthritis. Cell 1996a; 85(3)307–310
   PubMed Web of Science ®Google Scholar
• Feldmann M., Dower S., Brennan F. M. The role of cytokines in normal and pathological situations. Cytokines in Autoimmunity R.G. Landes Co. Austin, FM Brennan, M Feldmann, 1996b; 1–24
   Google Scholar
• Finkelman F. D., Katona I. M., Mosmann T. R., Coffman R. L. IFN-γ regulates the isotypes of Ig secreted during in vivo humoral immune responses. J. Immunol 1988; 140(4)1022–1027
   PubMed Web of Science ®Google Scholar
• Gantner F., Gotz C., Gekeler V., Schudt C., Wendel A., Hatzelmann A. Phosphodiesterase profile of human B-lymphocytes from normal and atopic donors and the effects of PDE inhibition on B-cell proliferation. Br. J. Pharmacol 1998; 123(6)1031–1038
   PubMed Web of Science ®Google Scholar
• Genain C. P., Roberts T., Davis R. L., Nguyen M. H., Uccelli A., Faulds D., Li Y., Hedgpeth J., Hauser S. L. Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. Proc. Natl. Acad. Sci. USA 1995; 92(8)3601–3605
   PubMed Web of Science ®Google Scholar
• Gondal J. A., Eiseman J. L., Alvares A. P. Regulation of heme metabolism and monooxygenases in liver and kidney: influence of therapeutically used gold compounds. J. Pharmacol. Exp. Ther 1987; 241(2)540–546
   PubMedGoogle Scholar
• Hannan M. T. Epidemiologic perspectives on women with arthritis: an overview. Arthritis Care Res 1996; 9(6)424–434
   PubMedGoogle Scholar
• Joosten L. A., Lubberts E., Durez P., Helsen M. M., Jacobs M. J., Goldman M., van den Berg W. B. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destraction. Arthritis Rheum 1997; 40(2)249–260
   PubMedGoogle Scholar
• Kammer G. M. The adenylate cyclase cAMP-protein kinase A pathway and regulation of the immune response. Immunol. Today 1988; 9(7–8)222–229
   PubMedGoogle Scholar
• Krause M., Kuhne G. Pharmacokinetics of rolipram in the rhesus and cynomolgus monkeys, the rat and the rabbit. Studies on species differences. Xenobiotica 1988; 18(5)561–571
   PubMed Web of Science ®Google Scholar
• Liblau R. S., Singer S. M., McDevitt H. O. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 1995; 16(1)34–38
   PubMedGoogle Scholar
• Lorence R. M., Edwards C. K., 3rd, Walter R. J., Kelley K. W., Greager J. A. In vivo effects of recombinant interferon-γ: augumentation of endotoxin-induced necrosis of tumors and priming of macrophages for tumor necrosis factor-α production. Cancer Lett 1990; 53(2–3)223–229
   PubMedGoogle Scholar
• McIntyre K. W., Shuster D. J., Gillooly K. M., Warrier R. R., Connaughton S. E., Hall L. B., Arp L. H., Gately M. K., Magram J. Reduced incidence and severity of collagen-induced arthritis in interleukin-12-deficient mice. Eur. J. Immunol 1996; 26(12)2933–2938
   PubMed Web of Science ®Google Scholar
• Mossmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol 1986; 136(7)2348–2357
   PubMedGoogle Scholar
• Mossmann T. R., Coffman R. L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol 1989; 7: 145–173
   PubMed Web of Science ®Google Scholar
• Nishikori T., Irie K., Suganuma T., Ozaki M., Yoshioka T. Anti-inflammatory potency of FR167653, a p38 mitogen-activated protein kinase inhibitor, in mouse models of acute inflammation. Eur. J. Pharmacol 2002; 451(3)327–333
   PubMedGoogle Scholar
• Ochel M., Vohr H. M., Pfeiffer C., Gleichmann E. IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J. Immunol 1991; 146(9)3006–3011
   PubMedGoogle Scholar
• Olivenstein R., Taha R., Minshall E. M., Hamid Q. A. IL-4 and IL-5 mRNA expression in induced sputum of asthmatic subjects: comparison with bronchial wash. J. Allergy Clin. Immunol 1999; 103(2 Pt 1)238–245
   PubMedGoogle Scholar
• Ross S. E., Williams R. O., Mason L. J., Mauri C., Marinova-Mutafchieva L., Malfait A. M., Maini R. N., Feldmann M. Suppression of TNF-α expression, inhibition of Th1 activity, and ameliolation of collagen-induced arthritis by rolipram. J. Immunol 1997; 159(12)6253–6259
   PubMed Web of Science ®Google Scholar
• Scola M. P., Thompson S. D., Brunner H. I., Tsoras M. K., Witte D., van Dijk M. A., Grom A. A., Passso M. H., Glass D. N. Interferon-γ:interleukin 4 ratios and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue. J. Rheumatol 2002; 29(2)369–378
   PubMedGoogle Scholar
• Sigidin Y. A., Loukina G. V., Skurkovich B., Skurkovich S. Randomized, double-blind trial of anti-interferon-γ antibodies in rheumatoid arthritis. Scand. J. Rheumatol 2001; 30(4)203–207
   PubMed Web of Science ®Google Scholar
• Snapper C. M., Paul W. E. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987; 236(4804)944–947
   PubMed Web of Science ®Google Scholar
• Sommer N., Loschmann P. A., Northoff G. H., Weller M., Steinbrecher A., Steinbach J. P., Lichtenfels R., Meyermann R., Riethmuller A., Fontana A. The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nat. Med 1995; 1(3)244–248
   PubMed Web of Science ®Google Scholar
• Toivonen M.-L., Linden I.-B., Gripenberg M., Vapaatalo H. The usability of the MRL/l mouse strain in detection of anti-rheumatic drugs. Agents Actions 1984; 15(5/6)578–583
   PubMedGoogle Scholar
• van Roon J. A., van Roy J. L., Duits A., Lafeber F. P., Bijilsma J. W. Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4. Ann. Rheum. Dis 1995; 54(10)836–840
   PubMedGoogle Scholar
• Woodruff T. M., Strachan A. J., Dryburgh N., Shiels I. A., Reid R. C., Fairlie D. P., Taylar S. M. Antiarthritic activity of an orally active C5a receptor antagonist against antigen-induced monoarticular arthritis in the rat. Arthritis Rheum 2002; 46(9)2476–2485
   PubMedGoogle Scholar
• Yamaki K., Li X., Uchida H., Alam A. H. M. K., Hossain Md. A., Yanagisawa R., Takano H., Taneda S., Hayashi H., Mori Y., Yoshino S. Effects of the phosphodiesterase IV inhibitor rolipram on Th1 and Th2 immune responses in mice. J. Pharm. Pharmacol 2004; 56(7)877–882
   PubMedGoogle Scholar
• Yamaki K., Uchida H., Harada Y., Li X., Yanagisawa R., Takano H., Hayashi H., Taneda S., Mori Y., Yoshino S. Effect of methotrexate on Th1 and Th2 immune responses in mice. J. Pharm. Pharmacol 2003a; 55(12)1661–1666
   PubMedGoogle Scholar
• Yamaki K., Uchida H., Harada Y., Yanagisawa R., Takano H., Hayashi H., Mori Y., Yoshino S. Effect of the nonsteroidal anti-inflammatory drugs indomethacin on Th1 and Th2 immune responses in mice. J. Pharm. Sci 2003b; 92(8)1723–1729
   PubMedGoogle Scholar
• Yin Z., Braun J., Neure L., Wu P., Liu L., Eggens U., Sieper J. Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis. Arthritis Rheum 1997; 40(10)1788–1797
   PubMedGoogle Scholar
• Yocum D. E. T cells: pathogenic cells and therapeutic targets in rheumatoid arthritis. Semin. Arthritis Rheum 1999; 29(1)27–35
   PubMedGoogle Scholar
• Yoshino S. Antigen-induced arthritis in rats is suppressed by the inducing antigen administered orally before, but not after immunization. Cell. Immunol 1995; 163(1)55–58
   PubMedGoogle Scholar
• Yoshino S., Murata Y., Ohsawa M. Successful induction of adjuvant arthritis in mice by treatment with a monoclonal antibody against IL-4. J. Immunol 1998; 161(12)6904–6908
   PubMedGoogle Scholar
• Yoshino S., Sasatomi E., Mori Y., Sagai M. Oral administration of lipopolysaccharide exacerbates collagen-induced arthritis in mice. J. Immunol 1999; 163(6)3417–3422
   PubMedGoogle Scholar